Metallopharmaceuticals I: DNA Interactions: Topics in Biological Inorganic Chemistry, cartea 1
Editat de Michael J. Clarke, Peter J. Sadleren Limba Engleză Hardback – 21 mai 1999
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1188.25 lei 6-8 săpt. | |
Springer Berlin, Heidelberg – 9 dec 2010 | 1188.25 lei 6-8 săpt. | |
Hardback (1) | 1194.28 lei 6-8 săpt. | |
Springer Berlin, Heidelberg – 21 mai 1999 | 1194.28 lei 6-8 săpt. |
Preț: 1194.28 lei
Preț vechi: 1456.43 lei
-18% Nou
Puncte Express: 1791
Preț estimativ în valută:
228.60€ • 239.70$ • 188.88£
228.60€ • 239.70$ • 188.88£
Carte tipărită la comandă
Livrare economică 29 ianuarie-12 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783540648895
ISBN-10: 3540648895
Pagini: 216
Ilustrații: XI, 200 p.
Dimensiuni: 156 x 234 x 17 mm
Greutate: 0.48 kg
Ediția:1999
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Topics in Biological Inorganic Chemistry
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3540648895
Pagini: 216
Ilustrații: XI, 200 p.
Dimensiuni: 156 x 234 x 17 mm
Greutate: 0.48 kg
Ediția:1999
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Topics in Biological Inorganic Chemistry
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchCuprins
Anticancer Activity of Cisplatin and Related Complexes.- Development of an Orally Active Platinum Anticancer Drug: JM216.- Trans-Platinum Compounds in Cancer Therapy: A Largely Unexplored Strategy for Identifying Novel Antitumor Platinum Drugs.- Chemistry and Biology of Multifunctional DNA Binding Agents.- Role of Metal Ions in Antisense and Antigene Stategies.- Sulfoxide Ruthenium Complexes: Non Toxic Tools for the Selective Treatment of Solid Tumour Metastases.- Non-Platinum Antitumor Compounds.
Textul de pe ultima copertă
Inorganic compounds offer much scope for the design of novel and therapeutic agents. The widespread use of paramagnetic metal complexes as effective contrast agents for magnetic resonsance imaging (e.g. Gd) demonstrates that the toxicity of metals can be finely controlled via the approriate choice of ligands. The successful targeting of radioisotopes again depends on ligand design and metal oxidation state. Bismuth and gold complexes have long been used in medicine but only recently have advances been made in understanding the molecular basis of their mechanism of action. New areas with clinical potential include the use of polyoxometallates and fullerenes as antiviral agents and vanadium complexes as insulin mimetics.
Caracteristici
The companion book series to the Journal of Biological Inorganic Chemistry Includes supplementary material: sn.pub/extras